A delivery system containing a transcatheter endoluminal prosthesis
The delivery system addresses the need for minimally invasive treatment of thoracic aortic aneurysms and dissections by using a self-expanding prosthesis with locking mechanisms for precise transcatheter implantation, reducing surgical risks and ensuring secure anchoring and blood flow continuity.
Patent Information
- Application Number
- PCT/EP2025/066999
- Authority / Receiving Office
- WO · WO
- Patent Type
- Applications
- Current Assignee / Owner
- Priority Date
- 2024-06-18
- Filing Date
- 2025-06-17
- Publication Date
- 2025-12-26
AI Technical Summary
Existing treatments for thoracic aortic aneurysms and dissections, particularly in the ascending aorta, involve high-risk open heart surgery, and there is a need for a minimally invasive, safe, and effective transcatheter delivery system for cardiac prostheses.
A delivery system comprising an inner tube, metal tube, and outer catheter shaft, with a self-expanding endoluminal prosthesis featuring distal and proximal locking mechanisms, allowing controlled deployment and anchoring of a stent-valve and stent-graft parts in the ascending aorta and aortic valve, facilitated by guide wires and rotating paddles for precise alignment and implantation.
Enables safe and precise implantation of aortic prostheses on a beating heart, reducing morbidity and mortality risks associated with open heart surgery, while providing secure anchoring and blood flow continuity.